Woodline Partners LP

Position in ACRS — Aclaris Therapeutics, Inc.

CIK 1784547 San Francisco, CA

Position in ACRS

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$8,522,475

+$2,951,389 QoQ

Shares Held

1,611,054

+8.4% QoQ

Ownership

1.09%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

#21

of 149 holders

Holding Since

Sep 2021

10 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. ACRS ranks #106 (0.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RVMD	Revolution Medicines, Inc.	2,002,863	$375,096,182
2	PTGX	Protagonist Therapeutics, Inc	1,414,173	$173,349,326
3	TNGX	Tango Therapeutics, Inc.	4,000,567	$125,057,724
4	BHVN	Biohaven Ltd.	7,660,280	$113,984,966
5	COGT	Cogent Biosciences, Inc.	2,603,162	$100,742,369
6	CYTK	Cytokinetics Inc	1,100,708	$93,769,314
7	RCUS	Arcus Biosciences, Inc.	3,007,798	$92,730,412
8	ROIV	Roivant Sciences Ltd.	2,500,673	$88,498,817

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$8,522,475	1,611,054	+8.4%	Shares	Sole	2026-08-14
2026-03-31	$5,571,086	1,485,623	+100.2%	Shares	Sole	2026-05-15
2025-12-31	$2,233,447	742,009	+335.9%	Shares	Sole	2026-02-17
2023-09-30	$1,166,075	170,230	+67.7%	Shares	Sole	2023-11-14
2023-06-30	$1,052,544	101,499	-55.1%	Shares	Sole	2023-08-14
2023-03-31	$1,829,974	226,202	-62.5%	Shares	Sole	2023-05-15
2022-12-31	$9,489,674	602,519	-13.6%	Shares	Sole	2023-02-14
2022-09-30	$10,970,890	697,007	+12.1%	Shares	Sole	2022-11-14
2022-06-30	$8,676,935	621,557	+4.5%	Shares	Sole	2022-08-15
2021-09-30	$10,705,824	594,768	—	Shares	Sole	2021-11-15
No filing history on record for this holder in this stock.